Literature DB >> 11488907

Regulation of MDR1 promoter activity in human breast carcinoma cells by protein kinase C isozymes alpha and theta.

P K Gill1, A Gescher, T W Gant.   

Abstract

Increased levels of the protein kinase C (PKC) isoenzymes alpha and theta occur in conjunction with MDR1 gene expression in cells and tissues that have acquired a multidrug resistance (MDR) phenotype. Studies using PKC activators or antisense strategies against PKC suggest that activation of PKC engenders MDR1 gene transcription. In this study the potential roles of PKC-alpha and PKC-theta in MDR1 gene transcriptional regulation were explored. Human-derived MCF-7 breast cancer cells that lack constitutive expression of PKC-alpha or PKC-theta at detectable levels were transfected with full-length PKC-alpha or PKC-theta genes driven by the ecdysone promoter. Stable transfectants were selected by use of the appropriate antibiotics. Treatment of these cells with ponasterone A induced expression of PKC that was catalytically active and underwent translocation and down-regulation on exposure to 12-O-tetradecanoyl-13-phorbol acetate (TPA). These cells were used to analyse PKC-mediated regulation of the MDR1 promoter by further transient transfection with either 1073 bp of the MDR1 gene promoter or deletion fragments thereof to -8 bp, each linked to a chloramphenicol acetyl transferase (CAT) reporter gene. In PKC-alpha expressing cells TPA caused activation of all promoter fragments to -29 bp. This finding suggests that TPA-inducible MDR1 transcription mediated through the TPA responsive factor early growth response 1 (EGR-1) in this region of the promoter may be due to activation of PKC-alpha. In contrast, PKC-theta activated only two MDR1 fragments, -982 and -612 bp. The effect of TPA on reporter gene expression was attenuated by the PKC inhibitor GF 109203X. These data suggest that MDR1 promoter transcription can be regulated by PKC-alpha and PKC-theta. The results support the search for therapeutic strategies directed specifically against PKC-alpha to ameliorate resistance of tumours against cytotoxic agents.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11488907     DOI: 10.1046/j.1432-1327.2001.02326.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  18 in total

Review 1.  Protein kinase C inhibitors.

Authors:  Helen C Swannie; Stanley B Kaye
Journal:  Curr Oncol Rep       Date:  2002-01       Impact factor: 5.075

2.  KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha.

Authors:  Ying Jiang; Michael Berk; Lisam Shanjukumar Singh; Haiyan Tan; Lihong Yin; C Thomas Powell; Yan Xu
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

3.  miR-124 represses FZD5 to attenuate P-glycoprotein-mediated chemo-resistance in renal cell carcinoma.

Authors:  Qing-Zhi Long; Yue-Feng Du; Xiao-Gang Liu; Xiang Li; Da-Lin He
Journal:  Tumour Biol       Date:  2015-04-12

4.  Protein kinase Cα protects against multidrug resistance in human colon cancer cells.

Authors:  Se-Kyoung Lee; Adeeb Shehzad; Jae-Chang Jung; Jong-Kyung Sonn; Jae-Tae Lee; Jeen-Woo Park; Young-Sup Lee
Journal:  Mol Cells       Date:  2012-05-23       Impact factor: 5.034

5.  Expression and function of classical protein kinase C isoenzymes in gastric cancer cell line and its drug-resistant sublines.

Authors:  Ying Han; Zhe-Yi Han; Xin-Min Zhou; Ru Shi; Yue Zheng; Yong-Quan Shi; Ji-Yan Miao; Bo-Rong Pan; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

6.  Caveolin-1 promotes resistance to chemotherapy-induced apoptosis in Ewing's sarcoma cells by modulating PKCalpha phosphorylation.

Authors:  Oscar M Tirado; Caitlin M MacCarthy; Naheed Fatima; Joaquín Villar; Silvia Mateo-Lozano; Vicente Notario
Journal:  Int J Cancer       Date:  2010-01-15       Impact factor: 7.396

7.  PKCalpha expression is a marker for breast cancer aggressiveness.

Authors:  Gry Kalstad Lønne; Louise Cornmark; Iris Omanovic Zahirovic; Göran Landberg; Karin Jirström; Christer Larsson
Journal:  Mol Cancer       Date:  2010-04-14       Impact factor: 27.401

8.  Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1.

Authors:  Ainslie Mitchell; Crispin R Dass; Lun-Quan Sun; Levon M Khachigian
Journal:  Nucleic Acids Res       Date:  2004-06-04       Impact factor: 16.971

Review 9.  The complexities of PKCα signaling in cancer.

Authors:  Adrian R Black; Jennifer D Black
Journal:  Adv Biol Regul       Date:  2020-11-23

10.  Synthesis of a dual functional anti-MDR tumor agent PH II-7 with elucidations of anti-tumor effects and mechanisms.

Authors:  Ye Su; Xin Cheng; Yaohong Tan; Yunhui Hu; Yuan Zhou; Juanni Liu; Yuanfu Xu; Yinliang Xie; Caiyun Wang; Yingdai Gao; Jianxiang Wang; Tao Cheng; Chunzheng Yang; Dongsheng Xiong; Hua Miao
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.